Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis.

Literature DB >> 26771414

Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis.

Athol U Wells¹, Ivan O Rosas^2,3.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Indoles

Year: 2016 PMID： 26771414 PMCID： PMC4731716 DOI： 10.1164/rccm.201510-2052ED

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

9 in total

Review 1. Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors: Ivan O Rosas; Paul F Dellaripa; David J Lederer; Dinesh Khanna; Lisa R Young; Fernando J Martinez
Journal: Ann Am Thorac Soc Date: 2014-04

Review 2. Subclinical interstitial lung disease: why you should care.

Authors: Tracy J Doyle; Gary M Hunninghake; Ivan O Rosas
Journal: Am J Respir Crit Care Med Date: 2012-02-23 Impact factor: 21.405

3. Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.

Authors: Ulrich Costabel; Yoshikazu Inoue; Luca Richeldi; Harold R Collard; Inga Tschoepe; Susanne Stowasser; Arata Azuma
Journal: Am J Respir Crit Care Med Date: 2016-01-15 Impact factor: 21.405

4. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

Authors: Athol U Wells; Sujal R Desai; Michael B Rubens; Nicole S L Goh; Derek Cramer; Andrew G Nicholson; Thomas V Colby; Roland M du Bois; David M Hansell
Journal: Am J Respir Crit Care Med Date: 2003-04-01 Impact factor: 21.405

5. Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old.

Authors: Susan J Copley; Athol U Wells; Katherine E Hawtin; Daren J Gibson; James M Hodson; Audrey E T Jacques; David M Hansell
Journal: Radiology Date: 2009-05 Impact factor: 11.105

6. A multidimensional index and staging system for idiopathic pulmonary fibrosis.

Authors: Brett Ley; Christopher J Ryerson; Eric Vittinghoff; Jay H Ryu; Sara Tomassetti; Joyce S Lee; Venerino Poletti; Matteo Buccioli; Brett M Elicker; Kirk D Jones; Talmadge E King; Harold R Collard
Journal: Ann Intern Med Date: 2012-05-15 Impact factor: 25.391

7. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors: Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal: N Engl J Med Date: 2014-05-18 Impact factor: 91.245

8. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Authors: Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard
Journal: N Engl J Med Date: 2014-05-18 Impact factor: 91.245

9. Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment.

Authors: Arata Azuma; Yoshio Taguchi; Takashi Ogura; Masahito Ebina; Hiroyuki Taniguchi; Yasuhiro Kondoh; Moritaka Suga; Hiroki Takahashi; Koichiro Nakata; Atsuhiko Sato; Shoji Kudoh; Toshihiro Nukiwa
Journal: Respir Res Date: 2011-10-28